View PDF Version
 
DOI: 10.1039/A800572I (Paper) Reference Section for: J. Chem. Soc., Perkin Trans. 1, 1998, 1669-1676

Antitumour imidazotetrazines. Part 36.1 Conversion of 5-aminoimidazole-4-carboxamide to imidazo[5,1-d[hair space]][1,2,3,5]tetrazin-4(3H[hair space])-ones and imidazo[1,5-a][1,3,5]triazin-4(3H[hair space])-ones related in structure to the antitumour agents temozolomide and mitozolomide

(Note: The full text of this document is currently only available in the PDF Version )

Yongfeng Wang, Richard T. Wheelhouse, Linxiang Zhao, David A. F. Langnel and Malcolm F. G. Stevens

Abstract

Novel 3-substituted imidazo[5,1-d[hair space]][1,2,3,5]tetrazinones 3 have been prepared by two routes: reaction of 5-diazoimidazole-4-carboxamide 2 and isocyanates, and nitrosative cyclisation of 5-amino-1-carbamoylimidazole-4-carboxamides 7. The latter cyclisations do not proceed efficiently when the 1-carbamoyl group bears an electron-donating alkyl group. 5-Amino-1-carbamoylimidazole-4-carboxamides 7 cyclise with triethyl orthoformate or triethyl orthobenzoate to yield imidazo[1,5-a][1,3,5]triazinones 15. A 1H NMR study of the decomposition of 8-carbamoyl-3-ethylimidazo[5,1-d[hair space]][1,2,3,5]tetrazin-4(3H[hair space])-one 3c in deuteriated phosphate buffer has shown that its ethylating capacity is attenuated by the unproductive generation of ethene. This observation explains why the ethylimidazotetrazine possesses weaker antitumour properties than the clinically-used congener temozolomide 3a.

References

  1. Part 35. Y. Wang, M. F. G. Stevens, T. Chan, D. DiBenedetto, Z. Ding, D. Gala, D. Hou, M. Kugelman, W. Leong, S. Kuo, J. L. Mas, D. P. Schumacher, B. P. Shutts, L. Smith and J. Zhan, J. Org. Chem., 1997, 62, 7288 Search PubMed.
  2. M. F. G. Stevens and E. S. Newlands, Eur. J. Cancer, 1993, 29A, 1045 CAS.
  3. E. J. Gray and M. F. G. Stevens, J. Chem. Soc., Perkin Trans. 1, 1976, 1492 RSC; E. J. Gray, M. F. G. Stevens, G. Tennant and R. J. S. Vevers, J. Chem. Soc., Perkin Trans. 1, 1976, 1496 RSC; E. J. Gray, H. N. E. Stevens and M. F. G. Stevens, J. Chem. Soc., Perkin Trans. 1, 1978, 885 RSC.
  4. M. F. G. Stevens, J. A. Hickman, R. Stone, N. W. Gibson, G. U. Baig, E. Lunt and C. G. Newton, J. Med. Chem., 1984, 27, 196 CrossRef CAS.
  5. E. S. Newlands, G. Blackledge, J. A. Slack, C. Goddard, C. J. Brindley, L. Holden and M. F. G. Stevens, Cancer Treat. Rep., 1985, 69, 801 Search PubMed.
  6. E. S. Newlands, M. F. G. Stevens, S. R. Wedge, R. T. Wheelhouse and C. Brock, Cancer Treat. Rev., 1997, 23, 35 CrossRef CAS.
  7. E. S. Newlands, S. M. O'Reilly, M. G. Glaser, M. Bower, H. Evans, C. Brock, M. H. Brampton, I. Colquhoun, P. Lewis, J. M. Rice-Edwards, R. D. Illingworth and P. G. Richards, Eur. J. Cancer, 1996, 32A, 2236 CrossRef CAS.
  8. N. M. Bleehen, E. S. Newlands, S. M. Lee, N. Thatcher, P. Selby, A. H. Calvert, G. J. S. Rustin, M. Brampton and M. F. G. Stevens, J. Clin. Oncol., 1995, 13, 910 Search PubMed.
  9. Y. Wang, M. F. G. Stevens, W. Thomson and B. P. Shutts, J. Chem. Soc., Perkin Trans. 1, 1995, 2783 RSC.
  10. B. J. Denny, R. T. Wheelhouse, M. F. G. Stevens, L. L. H. Tsang and M. F. G. Stevens, Biochemistry, 1994, 33, 9045 CrossRef CAS.
  11. A preliminary account of this work has been published: Y. Wang, P. R. Lowe, W. T. Thomson, J. Clark and M. F. G. Stevens, Chem. Commun., 1997, 363 Search PubMed.
  12. G. Ege, K. Gilbert and K. Maurer, Chem. Ber., 1987, 120, 1375 CAS.
  13. A. K. Saxena, S. Ahmad, K. Shanker, K. P. Bhargava and K. Kishor, Pharmazie, 1980, 35, 16 Search PubMed.
  14. G. U. Baig and M. F. G. Stevens, J. Chem. Soc., Perkin Trans. 1, 1987, 665 RSC.
  15. M. F. G. Stevens, J. A. Hickman, S. P. Langdon, D. Chubb, L. Vickers, R. Stone, G. Baig, C. Goddard, N. W. Gibson, J. A. Slack, C. Newton, E. Lunt, C. Fizames and F. Lavelle, Cancer Res., 1987, 47, 5846 CAS.
  16. R. H. Smith, S. R. Koepke, Y. Tondeur, C. L. Denlinger and C. J. Michejda, J. Chem. Soc., Chem. Commun., 1985, 936 RSC.
  17. A. S. Clarke, B. Deans, M. F. G. Stevens, M. J. Tisdale, R. T. Wheelhouse, B. J. Denny and J. A. Hartley, J. Med. Chem., 1995, 38, 1493 CrossRef CAS.
  18. S. M. O'Reilly, R. J. A. Harte, E. S. Newlands, T. T. Jones and P. M. Price, Proc. Am. Soc. Clin. Oncol., 1995, 5, 499 Search PubMed.
  19. T. A. Connors and J. R. Hare, Biochem. Pharmacol., 1976, 24, 2133 CrossRef; F. M. Schabel, Jr., Cancer Treat. Rep., 1976, 60, 665 Search PubMed.
  20. B. T. Golding, C. Bleasdale, J. McGinnis, S. Muller, H. T. Rees, N. H. Rees, P. B. Farmer and W. P. Watson, Tetrahedron, 1997, 53, 4063 CrossRef CAS.
  21. R. T. Wheelhouse, D. E. V. Wilman, W. Thomson and M. F. G. Stevens, J. Chem. Soc., Perkin Trans. 1, 1995, 249 RSC.
Click here to see how this site uses Cookies. View our privacy policy here.